Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Short-term Investments: 2022-2024

Historic Short-term Investments for Whitehawk Therapeutics (WHWK) over the last 3 years, with Dec 2024 value amounting to $18.6 million.

  • Whitehawk Therapeutics' Short-term Investments rose 288.59% to $124.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.7 million, marking a year-over-year increase of 288.59%. This contributed to the annual value of $18.6 million for FY2024, which is 59.60% down from last year.
  • Latest data reveals that Whitehawk Therapeutics reported Short-term Investments of $18.6 million as of FY2024, which was down 59.60% from $46.0 million recorded in FY2023.
  • In the past 5 years, Whitehawk Therapeutics' Short-term Investments registered a high of $133.5 million during FY2022, and its lowest value of $18.6 million during FY2024.
  • Over the past 3 years, Whitehawk Therapeutics' median Short-term Investments value was $46.0 million (recorded in 2023), while the average stood at $66.0 million.
  • Data for Whitehawk Therapeutics' Short-term Investments shows a maximum YoY crashed of 65.59% (in 2023) over the last 5 years.
  • Over the past 3 years, Whitehawk Therapeutics' Short-term Investments (Yearly) stood at $133.5 million in 2022, then plummeted by 65.59% to $46.0 million in 2023, then crashed by 59.60% to $18.6 million in 2024.